HOME >> BIOLOGY >> NEWS
New science investigations, a fresh team ready for Expedition Three on International Space Station

cks will continue to support existing and new experiments.

"We are doing science in all the disciplines, and the science is becoming more complex with every new expedition," said Uri. "With Expedition Three, we are pleased to bring a number of new scientists to the Space Station team, and look forward to continuing work with those who already have experiments on our newest orbital research facility."

Eight new experiments will get under way in the five research facilities, and 10 experiments -- started on Expedition One or Two -- will continue.

"One of the advantages of Space Station research is the flexibility to continue long-duration research over several expeditions, modifying research procedures and parameters to take advantage of intriguing results," said Uri. "We want science on the Station to be as much like science in an Earth-based laboratory as possible, but of course without gravity."

The first experiment to be mounted outside the Station -- the Materials International Space Station Experiment (MISSE) - will be delivered by the STS-105 crew and mounted outside the Station during an Extravehicular Activity, or space walk. MISSE will test the durability of hundreds of samples, ranging from lubricants to solar cell technologies.

By examining how coatings fare in the harsh environment of space, scientists can learn how to develop materials for future spacecraft and make materials last longer on Earth. Rachel Kamenetzky is the MISSE principal investigator at the Marshall Center, and the experiment is managed by Langley Research Center in Hampton, Va., and is a collaborative effort among NASA centers, the U.S. Air Force and private industry.

The first experiments with biological cell cultures also begin on the Station in Expedition Three, with delivery of a major facility: the Cellular Biotechnology Operations Support System (CBOSS).

"This will be our first opportunity to use a sophisticated bioreactor t
'"/>

Contact: Steve Roy
steve.roy@msfc.nasa.gov
256-544-0034
NASA/Marshall Space Flight Center News Center
8-Aug-2001


Page: 1 2 3 4

Related biology news :

1. Student science contest participation influences study, career choices, alumni say
2. Houston minority graduation rises in sciences, engineering as result of UH-led alliance
3. New Arizona State center brings science to policy on issues of water resources and urban growth
4. 4 October press briefing to focus on minority recruitment to science and engineering programs
5. Agronomy, crop, and soil science societies to meet Oct. 31 to Nov. 4 in Seattle
6. News tips from the Journal of Neuroscience
7. Former US Secretary of the Interior Bruce Babbitt to speak at science symposium
8. News tips from the Journal of Neuroscience
9. Discoveries in neuroscience
10. News tips from the Journal of Neuroscience
11. MSU group reviews Berkeley venture into brave new science funding world

Post Your Comments:
(Date:8/25/2015)... BELLEVUE, Wash. , Aug. 25, 2015 ... systems, announced today it will unveil its "Guardian S" ... at the National Tactical Officers Association Conference on August ... Guardian S is the first-ever commercially available energetically autonomous ... research and in-field trials and is protected by more ...
(Date:8/20/2015)... , Aug. 20, 2015 The wearable ... that are active and healthy. However, wearable technology ... hospital environment to help improve diagnostic capabilities and ... from the Wearable Technologies Conference 2015 , ... applications for wearables in healthcare.    ...
(Date:8/19/2015)... 19, 2015  VOXX International Corporation (Nasdaq: ... into a Definitive Agreement to purchase the assets, ... market leader EyeLock through an acquiring entity.  Upon ... controlling interest in the acquiring entity. The closing ... due diligence.  Expanding on its existing supply chain ...
Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5
(Date:8/26/2015)... 2015  Platform therapeutic company Symic Biomedical, Inc. ... $1.5M Phase II SBIR grant from the National ... therapeutic agent to reduce arteriovenous fistula (AVF) failures, ... renal disease (ESRD) patients undergoing hemodialysis. The two-year ... and Digestive and Kidney Diseases (NIDDK), will allow ...
(Date:8/26/2015)... HONG KONG , Aug. 26, 2015 ... "Company"), China,s leading provider of ... and stem cell storage services, today announced that the ... Holdings Limited ("MO2"), an entity wholly owned by Mr. ... the Company, has acquired the outstanding shares (the "Shares") ...
(Date:8/26/2015)... ... August 26, 2015 , ... PRC Clinical, ... new business relationships with local sponsors in southern California. The Clinical Trial Management Expert ... development processes and regulatory pathways., , Stem Cell Meeting ...
(Date:8/25/2015)... ... August 25, 2015 , ... A new optical ... is described by University of Illinois researchers in the Journal of Biomedical ... In “ Breast cancer diagnosis using spatial light interference microscopy ,” published 20 ...
Breaking Biology Technology:Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 3PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 2PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 3New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 2New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 3New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 4
Cached News: